The invention relates to development of live attenuated trivalent combination vaccine for Goat Pox, Sheep Pox and PPR disease. The vaccine is in fully lyophilised form and has improved thermostability. The vaccine is given intra-dermally at 0.2 ml per animal. The vaccine is stable for at least 18 months and capable ...

The present invention relates to a vaccine composition with improved thermostability comprising inactivated antigen of sheep pox virus; an inactivated antigen of goat pox virus; an inactivated antigen of Peste-des-petits-ruminants virus; and excipients, wherein the pH of the composition ranges between 7.2 and 7.4. T...

The present invention relates to the field of vaccines. In particular, the invention relates to providing an efficient & effective vaccine for Chikungunya. More particularly, the invention provides an inactivated vaccine for Chikungunya virus infection. The vaccine is immunogenic and elicits protective immune respon...

The present invention relates to the field of vaccines. In particular, the invention relates to providing an efficient & effective vaccine for Chikungunya. More particularly, the invention provides a live-attenuated vaccine composition for chikungunya virus infection. The vaccine composition is immunogenic and elici...